During the past decade, FUNDACAO PIO XII Hospital de Cancer de Barretos conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 22 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 15 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "FUNDACAO PIO XII Hospital de Cancer de Barretos" #1 sponsor was "Pfizer" with 11 trials, followed by "EMD Serono Research & Development Institute, Inc." with 6 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Bayer" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "FUNDACAO PIO XII Hospital de Cancer de Barretos" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 6 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator and "PPD" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "FUNDACAO PIO XII Hospital de Cancer de Barretos" are "Non-small Cell Lung Cancer" (4 trials), "Head and Neck Cancer" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "FUNDACAO PIO XII Hospital de Cancer de Barretos" in a lesser frequency.

Most popular intervention types in "FUNDACAO PIO XII Hospital de Cancer de Barretos" are "Drug" (52 trials), "Biological" (6 trials), "Radiation" (5 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (9 trials), "Cisplatin" (7 trials), "Paclitaxel" (7 trials) and "Pemetrexed" (7 trials). Other intervention names were less common.

The vast majority of trials in "FUNDACAO PIO XII Hospital de Cancer de Barretos" are 44 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "FUNDACAO PIO XII Hospital de Cancer de Barretos". undefined are not yet recruiting, 13 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in FUNDACAO PIO XII Hospital de Cancer de Barretos, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in FUNDACAO PIO XII Hospital de Cancer de Barretos, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".